oxytocin vs oxytocin & methylergometrine in controlling intrapartum cesarean sectio
Phase 2
- Registration Number
- CTRI/2023/07/055548
- Lead Sponsor
- AIIMS Jodhpur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
pregnant women 18 years and above
laboring patients who undergo a cesarean section
Exclusion Criteria
placental / uterine abnormalities
chronic HTN , Gestational HTN, Preeclampsia
HIV/AIDS on protease inhibitors
history of Coronary heart disease
history of hypersensitivity to methylergometrine
underlying uncorrected structural heart disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the effectiveness of multimodal prophylactic uterotonic x 24 hours post deliveryTimepoint: INTRAOPERATIVELY
- Secondary Outcome Measures
Name Time Method blood loss estimation <br/ ><br>hb fall post cesarean <br/ ><br>uterine tone assessment <br/ ><br>patient requiring blood transfusionTimepoint: blood loss ( 2 hours ) <br/ ><br>hb fall post cesarean (24 hours) <br/ ><br>uterine tone assessment (4 mins ) <br/ ><br>patient requiring blood transfusion( till the day of discharge )